Post COVID-19 Mucormycosis in Mandible-Case Report of Two Rare Cases
Published: 2023-02-28
Page: 40-47
Issue: 2023 - Volume 6 [Issue 2]
Sanjay Yadav *
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
Namrata Jayasheel
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
Sima Odedra
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
Piyush Asnani
Oral Maxillofacial Pathology and Oral Microbiology, Government Dental College and Hospital, Gujarat University, Ahmedabad, Gujarat, India.
*Author to whom correspondence should be addressed.
Abstract
Mucormycosis, also known as black fungus, is a fulminant fungal infection that is reported most often in diabetic and immunocompromised individuals is a life-threatening, invasive fungal infection. After the COVID-19 pandemic, there was a significant rise in the Mucormycosis cases reported in the Maxillofacial region which was attributed to the unbalanced use of steroids to avoid the cytokine storm in covid patients. The majority of the cases reported were of rhinocerebral/orbital or maxillary areas. Very few reports describing the Muromycosis involving mandible have been published on the online database. So here, in this case, report a brief of two cases of Mucormycosis involving the mandible have been described its clinical presentation and histopathologic features.
Keywords: Mandibular Mucor, COVID associated mucormycosis, diabetic, maxillofacial infection
How to Cite
References
Mehta S, Pandey A. Rhino‑orbital mucormycosis associated with COVID‑19. Cureus 2020;12:e10726.
Song G, Liang G, Liu W. Fungal co‑infections associated with global COVID‑19 pandemic: A clinical and diagnostic perspective from China. Mycopathologia 2020;185:599‑606.
Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser. 1989;47:243‑71.
Eisenberg L, Wood T, Boles R. “Mucormycosis,” Laryngoscope. 1977; 87(3):347–356.
Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021 Mar 4;9(3):523. DOI: 10.3390/microorganisms9030523. PMID: 33806386; PMCID: PMC8000977
Mandibular mucormycosis following SARS-CoV-2 infection – A case report and review of Aafiya Ambereen a, Sajjad A. Rahman a, Suhailur Rehman b, Kamran Zaidi a, S.H. Arif b
Montefusco L, Ben Nasr M, D’Addio F, Loretelli C, Rossi A, Pastore I, et al. Acute and long‑term disruption of glycometabolic control after SARS‑CoV‑2 infection. Nat Metab 2021;3:774‑85.
Mishra N, Mutya VS, Thomas A, Rai G, Reddy B, Mohanan AA, et al. A case series of invasive mucormycosis in patients with COVID‑19 infection. Int J Otorhinolaryngol Head Neck Surg 2021;7:867‑70.
Sen M, Honavar SG, Bansal R, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69(7): 1670-1692. DOI:10.4103/ijo.IJO_1565_21
Agarwal S, Anand A, Ranjan P, Meena VP, Ray A, Dutta R, et al. Case of mucormycosis of mandible after self‑extraction of teeth incidentally detected to have chronic granulomatous disease: Case report and literature review. Med Mycol Case Rep 2020;28:55‑9.
Oswal NP, Gadre PK, Sathe P, Gadre KS. Mucormycosis of mandible with unfavorable outcome. Case Rep Dent. 2012;2012:257940. DOI: 10.1155/2012/257940. Epub 2012 Jun 20. PMID: 22779014; PMCID: PMC3388289
Warris A, Henriet SS. Invasive fungal infections in the child with chronic granulomatous disease. Curr Fungal Infect Rep. 2014;8:37‑44.
Aggarwal P, Saxena S, Bansal V. Mucormycosis of maxillary sinus. J Oral Maxillofac Pathol. 2007;11:66‑9.
Verma M, Sharma R, Verma N, Verma K. Rhinomaxillary mucormycosis presenting as palatal ulcer: A case report with comprehensive pathophysiology. J Oral Maxillofac Pathol. 2020;24:558‑ 62.
Dalimot JJ, Smith IMC, Gerkrath J, Hartmann S, Cornely OA, Lee SC, Heitman J, Rickerts V. Identification of Mucormycosis by Fluorescence In Situ Hybridization Targeting Ribosomal RNA in Tissue Samples. J. Fungi. 2022;8:289. Available:https://doi.org/10.3390/jof8030289